SIONNA THERAPEUTICS INC (SION:NASDAQ)
$6.06 -0.11 (-1.7828%)
Analysed SIONNA THERAPEUTICS INC (SION:NASDAQ) News Sources
Why Vertex Pharma Popped, As A Key Rival Plummeted 92%
10-08-2026
yahoo.com
Sionna cystic fibrosis drug fails key trial, removing threat to Vertex
10-08-2026
biopharmadive.com
Sionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint
10-08-2026
advfn.com
Why Sionna Therapeutics Stock Is Crashing 91% to a Record Low
10-08-2026
yahoo.com
SION Stock On Track For Worst Day Ever After 90% Drop — What’s Driving The Selloff?
10-08-2026
stocktwits.com
Sionna Therapeutics (SION) Halts Lead Cystic Fibrosis Drug After Phase 2 Failure
11-08-2026
yahoo.com
Sionna Therapeutics stock falls 92% after SION-719 trial failure
11-08-2026
qz.com
Sionna Therapeutics (SION) Stock Still Looks Cheap After The 90% Fall
12-08-2026
yahoo.com
Sionna Therapeutics (SION) Is Down 86.8% After Halting SION-719 And Refocusing Its CF Pipeline – Has The Bull Case Changed?
13-08-2026
yahoo.com
Sionna Therapeutics (SION) Resets After Trial Miss, Is The Discount Now Too Deep?
13-08-2026
yahoo.com
What is the current price of SIONNA THERAPEUTICS INC (SION:NASDAQ)?
The current price of SIONNA THERAPEUTICS INC (SION:NASDAQ) is $6.06.
SIONNA THERAPEUTICS INC (SION:NASDAQ) absolute price change since previous trading day?
The absolute price change of SIONNA THERAPEUTICS INC (SION:NASDAQ) since the previous trading day is $-0.11.
SIONNA THERAPEUTICS INC (SION:NASDAQ) percentage price change since previous trading day?
The percentage price change of SIONNA THERAPEUTICS INC (SION:NASDAQ) since the previous trading day is -1.7828%.
What is the most recent average sentiment score for SIONNA THERAPEUTICS INC (SION:NASDAQ)?
The most recent average sentiment score for SIONNA THERAPEUTICS INC (SION:NASDAQ) is 42 out of 100.
What is the most recent average sentiment for SIONNA THERAPEUTICS INC (SION:NASDAQ)?
The most recent sentiment for SIONNA THERAPEUTICS INC (SION:NASDAQ) is .
SEC-8K** Filing Available For SIONNA THERAPEUTICS INC (SION:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.